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Nonenzymatic Glucosylation of Rat Albumin 
STUDIES IN VITRO AND IN VIVO* 
(Received for publication, April 24, 1979) 
James F. Day,* Robert W. Thornburg, Suzanne R. Thorpe, and John W. Baynesg 
From the Department of Chemistry and School of Medicine, University of South Carolina, Columbia, South Carolina 29208 
Incubation of rat serum with o-[6-3H]glucose in vitro 
resulted in nonenzymatic glucosylation of serum pro- 
teins. Analysis of freshly isolated rat albumin by ion 
exchange chromatography indicated that the glucosyl- 
ated albumin accounts for 6.7 + 0.9% of total albumin 
in normal rat serum. Glucosylation of rat albumin in 
vitro was first order with respect to glucose and albu- 
min concentrations and occurs primarily (>90%) at in- 
trachain lysine residues. Kinetic analysis and inhibition 
of glucosylation by aspirin suggest that 1 reactive ly- 
sine residue is the primary site of glucosylation. Less 
than 5% of the radioactivity from [6-3H]glucosyl-albu- 
min was released as glucose or mannose by hydrolysis 
conditions normally used for the analysis of neutral 
sugars in glycoproteins. Studies in viva demonstrated 
that the half-life of albumin in normal rats was unaf- 
fected by the addition of 1 mol of glucose/mol of albu- 
min. In addition, glucosylation was found to be a stable 
modification since ‘251-albumin isolated up to 3 days 
after injection of glucosylated 1261-albumin was re- 
covered only in the glucosylated fraction. In contrast, 
following injection of unglucosylated ‘2SI-albumin there 
was a gradual shift of lz51 radioactivity to the glucosyl- 
ated albumin fraction, as would be predicted for non- 
enzymatic glucosylation occurring in the circulation. 
Finally, levels of glucosylated albumin isolated from 
diabetic rats (alloxan induced) were significantly (4- 
fold) elevated 4 days after withdrawal from insulin 
therapy. These studies indicate that the rat should be 
a suitable animal model for in uivo studies on nonen- 
zymatic glucosylation of albumin and other serum pro- 
teins in normal and diabetic metabolic states. 
A general mechanism for nonenzymatic glucosylation of 
protein is outlined in Fig. 1. Free amino groups in protein 
react with the acyclic form of glucose to yield a Schiff-base 
intermediate which can undergo the Amadori Rearrangement 
to a stable ketoamine derivative, which then cyclizes to the 
hemiketal structure (2). Prolonged elevation of blood glucose 
in diabetes causes an increase in levels of nonenzymatically 
glucosylated hemoglobin, HbAr,, in erythrocytes (3); this post- 
translational modification affects hemoglobin’s oxygen affinity 
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(4, 5) and sensitivity to the allosteric effector, 2,3-diphospho- 
glycerate (5, 6). It has been hypothesized (7) that nonenzy- 
matic glucosylation of other body proteins may also induce 
changes in their chemical, physical, and ultimately, biological 
properties, leading eventually to the pathological sequelae of 
diabetes. This hypothesis is supported by a growing body of 
evidence from clinical experience (8, 9) and animal model 
studies (lo), which indicates that chronic, subclinical hyper- 
glycemia, rather than the insulin deficiency itself, may be the 
major factor contributing to the progressive, secondary com- 
plications of diabetes. Stevens et al. (11) have, in fact, recently 
demonstrated that nonenzymatic glucosylation of cy-crystallins 
in lens cultures in vitro causes aggregation and precipitation 
of the crystallins. Their observations suggest that a similar 
process occurring in uiuo may contribute to the development 
of cataracts in diabetic patients. 
In a recent communication (12) we reported that several 
classes of human serum proteins are also subject to nonenzy- 
matic glucosylation in vitro, and that albumin isolated from 
normal human serum contains about 8% of a glucosylated 
derivative. Bailey et al. have also detected glucosylated lysine 
residues in albumin, erythrocyte membrane proteins (13), and 
collagens (14). Thus, it appears that numerous proteins in the 
body may be continuously modified by nonenzymatic gluco- 
sylation. By analogy to the observations with hemoglobin, the 
rates and extents of glucosylation of other proteins may also 
be enhanced in diabetic hyperglycemia. 
Identification of specific proteins subject to nonenzymatic 
glucosylation and its effects on protein function and metabo- 
lism are essential for evaluating the hypothesized relationship 
between hyperglycemia and the chronic pathophysiology of 
diabetes. Since much of this work can be most readily carried 
out in animal model systems, we have undertaken a study of 
serum protein glucosylation in the rat, in order to establish 
that this animal will be a satisfactory model for the human 
system. We present here in vitro experiments parallel to those 
previously reported for glucosylation of human serum proteins 
(12) as well as studies on the physical and chemical parameters 
affecting the kinetics of glucosylation. In addition, in uivo 
studies are reported identifying the body compartment in 
which glucosylation occurs, and the effect of glucosylation on 
the survival of albumin in the circulation. Finally, we establish, 
for the first time, that the serum concentration of glucosylated 
albumin is significantly elevated in diabetic rata. 
MATERIALS AND METHODS 
Rat serum albumin was prepared from fresh rat serum by affinity 
chromatography on Affi-Gel Blue (Bio-Rad) (151, followed by gel 
chromatography on Bio-Gel P-156 (Bio-Rad), or purchased from 
Miles Laboratories. n-[B-“H]Glucose (34 Ci/mmol), L-[3,4,5-3H]leu- 
tine (129.8 Ci/mmol) and L-[G-“H] serine (1 to 5 Ci/mmol) were 
purchased from New England Nuclear, and Na”“I (carrier-free) from 
Amersham/Searle. Penicillin-streptomycin was obtained from Grand 






































FIG. 1. General reaction scheme for the nonenzymatic glu- 
cosylation of protein. 
Incubations 
Albumin solutions and rat serum containing 100 units/ml of peni- 
cillin and 100 pg/ml of streptomycin were incubated in the dark at 
desired temperatures. Albumin solutions (5 to 50 mg/ml) were pre- 
pared in Dulbecco’s phosphate-buffered saline (16) containing 1 to 50 
mM glucose. Serum was incubated under an atmosphere of 95% 02, 
5% CO? to maintain pH 7.3 to 7.4. Trace amounts of [6-“HIglucose 
were added to incubation mixtures to obtain desired specific activities. 
Assays 
Acid-precipitable radioactivity was determined by adding 25+1 
aliquots of incubation mixtures to 50 ~1 of a bovine serum albumin 
solution (10 mg/ml) and precipitating with 1 ml of cold 10% trichlo- 
roacetic acid. Pellets were washed twice by centrifugation and the 
final pellet was redissolved in 500 ~1 of Hz0 and counted for radioac- 
tivity in Beckman Instruments Co. Bio-Solv EP. 
Glucosylated protein was separated from nonglucosylated protein 
by carboxymethylcellulose chromatography at pH 4.65 as previously 
described (12). Glucosylated protein was detected using the thiobar- 
bituric acid procedure of Fliickiger and Winterhalter (17) which 
measures 5-hydroxymethylfurfural released following hydrolysis of 
ketoamine adducts of protein. Hydroxymethylfurfural was used as 
the standard in these assays. 
Amino Acid Analyses 
Proteins in 6 N HCl were gassed with NZ in a sealed tube and 
hydrolyzed at 100°C for 24 h, and amino acid analyses were carried 
out on a Beckman model 119-C analyzer. For identification of gluco- 
sylated amino acids, n-[6-“HIglucose-labeled albumin was dissolved 
in 0.1 M NaBH4 in 0.1 M NaOH, to a final protein concentration of 7 
mg/ml; the mixture was incubated with shaking at 25°C for 4 h and 
then dialyzed and lyophilized. Following hydrolysis of the reduced, 
glucosylated albumin in 6 N HCl as described above, the sample was 
divided in half. One portion was analyzed directly for ninhydrin- 
positive material. L-[:‘H]Leucine (70,000 cpm) and L-[:‘H]serine (20,000 
cpm) were added as internal reference standards to the second por- 
tion, which was then applied to the analyzer column, but the effluent 
from the column was fed directly into a fraction collector; fractions 
were then counted for radioactivity. Glucitol-lysine was prepared 
from n-[6-‘H]glucose and lysine as described by Bailey et al. (13), and 
purified by chromatography on Amberlite MB (Mallinckrodt). 
Carbohydrate Analyses 
Carbohydrates were separated by high pressure liquid chromatog- 
raphy using the procedure of Lee et al. (18.19). For measurements of 
radioactivity in glucose or mannose following acid hydrolysis of D-[S- 
‘HIglucose-labeled albumin, unlabeled glucose and mannose were 
added to samples at the end of the hydrolysis; the effluent from the 
column was fed into a fraction collector, and aliquots of the fractions 
were monitored for both carbohydrate, using the anthrone reagent 
(20), and radioactivity. 
In Vivo Experiments 
Half-life Studies-Unglucosylated albumin was iodinated using 
the lactoperoxidase method (21) and labeled, monomeric albumin was 
isolated by Bio-Gel P-150 chromatography; the final specific activity 
was 1.3 x 10” cpm/mg. Two milligrams of this material were gluco- 
sylated in 20 mM glucose at 37°C for 3 days, and then separated into 
““I-glucosylated and ““I-unglucosylated albumin by carboxymethyl- 
cellulose chromatography. Rats were injected intracardially with 
either 1 mg of ‘2”I-glucosylated or 0.85 mg of ““I-unglucosylated 
albumin; radioactivity was determined in 50 ~1 of plasma samples 
obtained from lateral tail veins (22) over a 4-day period in order to 
compare the circulating half-lives of the two forms of albumin. In 
separate experiments, 1 ml of blood was removed by cardiac puncture 
at 1 and 3 days postinjection of each of the iodinated forms of 
albumin. Albumin was reisolated by affinity chromatography and 
then carboxymethylcellulose chromatography, for determination of 
recovery of Is51 radioactivity in glucosylated and unglucosylated al- 
bumins. 
Studies with Diabetic Rats-Rats (male, Sprague-Dawley, 125 to 
150 g) were made diabetic by the intravenous injection of 35 mg/kg 
of alloxan. Animals whose blood glucose exceeded 300 mg/lOO ml at 
2 days postinjection were classified as diabetic. These animals were 
then maintained with daily subcutaneous injections of 4 units of 
protamine zinc insulin for 2 weeks, when the therapy was stopped. 
Ninety-six hours after the last insulin injection, the rats were anes- 
thetized with ether and 1 to 2 ml of blood were removed by cardiac 
puncture. At the same time, blood was also obtained from a second 
set of alloxan-treated rats maintained on insulin therapy throughout, 
and from a sex-, age-, and weight-matched control group. Blood 
glucose was determined by a glucose oxidase-peroxidase method 
(Sigma), and serum albumin was purified and fractionated into unglu- 
cosylated and glucosylated albumin as described above. 
RESULTS 
In Vitro Studies-Radioactivity gradually accumulates in 
an acid-precipitable fraction during the incubation of rat 
serum with tracer amounts of [6-“HIglucose (Fig. 2). The 
reaction rate was linear for at least 200 h at room temperature 
by which time about 10% of glucose radioactivity was incor- 
porated into protein. Based on the approximate specific activ- 
ity of the [3H]glucose, 4 x 10” cpm/pmol, an average molecular 
weight of serum proteins of 1 x 105, and a serum protein 
concentration of approximately 70 mg/ml, the incorporation 
of 2 X 10” cpm into protein in 1 ml of serum represents an 
average of 0.7 mol of glucose/m01 of protein. 
Following 200 h of incubation, reaction mixtures were di- 
alyzed against pH 7.8, Tris-HCl at 4”C, overnight, with essen- 
tially quantitative recovery of acid-precipitable radioactivity. 
When the dialysate was chromatographed on Sephadex G-200 
FIG. 2. Time-dependent formation of acid-precipitable [6- 
3H]glucose radioactivity in rat serum in vitro. One milliliter of 
rat serum was incubated with 2 x 10’ cpm (-1 pg) of [6-“HIglucose at 
25°C under sterile conditions, and aliquots were removed for deter- 
mination of acid-precipitable radioactivity as described under “Ma- 
terials and Methods.” Data are expressed as precipitable counts per 

























9396 Nonenzymatic Glucosylation of Serum Proteins 
(Fig. 3), radioactivity was found associated with each of the 
major molecular weight classes of serum protein. Since the 
highest specific activity (counts per mm/Am) was observed 
in the region corresponding to serum albumin, we investigated 
nonenzymatic glucosylation of purified rat albumin in further 
detail. 
Incorporation of [6-‘H]glucose into albumin was also linear 
for at least 200 h at 22”C, as shown in Fig. 4. By 200 h, about 
50% of the albumin had been converted to the glucosylated 
form. The rate of glucosylation was stimulated approximately 
1.5-fold by the addition of 1 mg/ml of NaBH&N. The 
stimulation by BHaCN- probably results from selective re- 
duction (23) of S&&base adducts formed between glucose 
and protein, pulling the initial equilibrium reaction to the 
right (Fig. 1). In contrast, aspirin inhibited the rate of gluco- 
sylation, suggesting that at least some glucose is being incor- 
porated at the lysine residue in rat albumin, which is the site 
of acetylation by aspirin (see below). 
The glucosylated rat albumin prepared in vitro was sepa- 
rable from unglucosylated albumin by chromatography on 
CM-cellulose (Fig. 5A). However, in contrast to our observa- 
tions with human albumin (12), glucosylated rat albumin 
eluted from the column after the unglucosylated form. More 
than 95% of the protein-bound radioactivity from [6-3H]glu- 
case was associated with the second protein peak. Peak If 
yielded a strong positive reaction in the thiobarbituric acid 
test for ketoamine derivatives of protein (I7), white a weak 
but reproducible reaction was observed in Peak I (data not 
shown). When native albumin, freshly purified from rat serum 
by affinity chromatography, was chromatographed as above, 
two peaks of protein were observed (Fig. 5B), corresponding 
precisely to Peaks I and II obtained from the in vitro incu- 
bation (Fig. 5A); Peak II accounted for about 96% of the 
thiobarbituric acid reactivity. Ammo acid analyses of Peaks I 
and II are essentially identical (Table I), and agree closely 
with results from hydrolysis of a commercia1 sample of puri- 
fied rat albumin and published data (24). Based on relative 
areas under Peaks I and II, normal rat serum contains about 
6.7 f 0.9% (mean zb S.D., II = 8) glucosylated albumin. 
Verification that a lysine residue is the major site of gluco- 
sylation was obtained by amino acid analysis of an acid 
hydrolysate of NaBH,-reduced [6-“HIglucose-labeled albumin 
(Fig. 6). More than 90% of radioactivity obtained from hy- 
drolysis of the protein co-chromatographed with the product 
obtained from a separate hydrolysis of glucitol-lysine in the 
I I 
FRACTION NUMBER 
Fta. 3. Sephadex C-200 chromatography of rat serum after 
200 h of incubation with [6-aH]~lucose. Hat serum was incubated 
aa in Fig. 2, dialyzed for 16 h at 4’C against two changes (1066 
volumes) of 0.1 M Tris-HCl, pH 7.8,l.O M NaCl, and chromatographed 
on a G-260 column (1.5 x 63 cm, I-ml fractions). The cdumn was 
eluted with the same buffer and the effluent monitored for protein 
and “H radioactivity. Arrows indicate positions of IgM, IgG, and 
albumin, respectively. 
FIa. 4. Comparison of the effects of NaBfI&N and aspirin 
TIMlXDAYS) 
on the incorporation of (S3~gllucose into rat albumin in uitm. 
Purified rat albumin, 7 mg, was incubated in 1 ml of Dulbecco’s 
phosphate-buffered saline (16) containing 5 rnM glucose, 2 x 10’ cpm 
of [6-“H]ghtcose, alone or with 17 mM NaBHEN or with 0.5 mM 
aspirin, and acid-precipitable radioactivity was determined as de- 
scribed under “Materials and Methods.” 
0.50 5.0 6 g 
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Fro. 5. Separation of ghnzosylated rat Elfbumin from unglu- 
cosylated albumin by carboxymethyleelluhrse chromatogra- 
phy. Samples in 0.01 M sodium acetate, pH 4.65, were applied to a 
column (17.5 x 2 cm, l-ml fractions) of carboxymethylcellul and 
washed with 10 column volumes of starting buffer. At the position 
indicated by the arrow, the column was eluted using a 150~ml gradient 
of 0.01 to 0.5 M sodium acetate, pH 4.65. A, chromatography of 
albumin following glucosylation with [6-‘Hlglucose in vitro; B, chro- 
matography of albumin purified from fresh rat serum; fractions mon- 
itored for protein and for ketoamine structures using the thiobarbit- 
uric acid assay (17). 
presence of albumin (Peak II, Fig. 6). Thii product is not the 
hexitol-lysine itself (Pecsk Z, Fig. 6), but probably an anhydro- 
derivative of hexitol-lysine produced during the hydrolysis 
(13). Derivatives of both mannitol- and glucitol-lysine should 
be obtained since the borohydride reduction of the ketoamine 
is not stereospec&, however these isomers are apparently 
not resolved in the standard elution scheme on the amino acid 
analyzer. The small amount of radioactive material appearing 
after Peak II has not been identified. From these results, we 
conclude that intrachain lysine residues, rather than the NH*- 
terminal glutamate, are the primary sites of glucosylation of 
rat albumin. 
Table II summarizes the results from carbohydrate analyses 
of hydrolysates of [6-“H]glucose-labeled albumin (prepared 
nonenzymatically in vitro) carried out under conditions com- 

























Nonenzymatic Ghcosylation of Serum Proteins 
Hydrolysis for 2 or 4 h in 2 N trifluoroacetic acid, HCl, H2S04, 
or 4 N acetic acid resulted in the recovery of no more than 5% 
of the starting radioactivity in glucose and mannose, under 
any of the conditions studied. More than 99% of the starting 
radioactivity was recovered as high molecular weight material, 
either excluded from or partially included in a Bio-Gel P-2 
column. These data indicate that nonenxymatically attached 
glucose is likely to contribute only trace amounts of glucose 
or mannose to analyses of neutral sugars in glycoproteins. 
The data in Figs. 7 to 9 summarize experiments describing 
some of the kinetic and thermodynamic properties of the 
glucosylation of albumin in vitro. The influence of glucose 
and albumin concentrations on the rate of glucosylation are 
shown in Fig. 7A and 8A, respectively. At higher glucose 
concentrations, the rate of glucosylation appeared to decline 
appreciably after the addition of 1 mol of glucose/mol of 
protein. The initial rate of glucosylation of albumin in vitro is 
first order with respect to both glucose (Fig. 7B) and albumin 
(Fig. 8B) concentration in the incubation mixture, and second 
order overall. As shown in Fig. 9, the rate of glucosylation is 
TABLE I 
Amino acid analyses of rat albumins 
COmmSrCial 
albumin’ 
96 composition (nwl/lOO mol) 
ASP 13.90 14.09 13.53 
Thr 5.39 5.38 5.26 
Ser 4.99 5.12 4.94 
Glu 16.74 16.81 16.23 
Pro 5.24 5.19 4.91 
GUY 4.21 4.23 4.31 
AIa 12.23 12.35 12.77 
CYS 2.56 2.54 2.42 
Val 3.57 3.51 3.45 
Ile 0.77 0.77 0.82 
IA?U 7.97 a.12 a.02 
TY 4.81 4.89 4.58 
Phe 4.80 4.80 4.70 
His 2.35 2.35 2.39 
LYS 8.14 8.19 8.16 
Arg 3.60 3.70 3.69 
n Amino acid analysis carried out following hydrolysis of protein 
(1 mg/ml) in 6 N HCl as described under “Materials and Methods.” 
b Albumin was purified from rat serum by affinity chromatography 
on Affi-Gel Blue (15) and separated into glucosylated and ungluco- 
sylated fractions by carboxymethylcellulo chromatography as de- 
scribed for Fig. 4. 
’ Hat albumin was purchased from Miles Laboratories. 
A I 




FIG. 6. Amino acid analysis of rat albumin after glucosyla- 
tion with [&‘H]glucose and reduction with NaBH,. Hat albumin 
was glucosylated with [6-3H]glucose, purified by carboxymethylcel- 
lulose chromatography, reduced with NaBI&, and hydrolyzed for 
amino acid analysis as described under “Materials and Methods.” 
Radioactivity at “L” represents added L-[JH]leucine marker, contain- 
ing a trace contaminant of isoleucine. Peak Z represents position of 
elution of authentic [“Hlglucitol-lysine. Peak ZZ represents position 
of elution of the “H-labeled product obtained after hydrolysis of 
authentic [‘Hlglucitol-lysine at 199°C for 24 h in 6 N HCl in the 
presence of 1 mg/ml of albumin. 
TABLE II 
Recovery of radioactive glucose and mannose following hydrolysis 
of [6-3H]glucose-labeled albumin 
Hydrolysis conditions” 56 recoveryh 
Acid Time MZiIUlOSZ Glucose 
(hl 




2 N H&04 2 
4 










n [6-‘H]Glucose-labeled albumin (1 mol of glucose/mol of albumin), 
0.25 mg/ml, containing -40,000 cpm was hydrolyzed in acids at 100°C 
for various times. 
’ Carbohydrates were separated by ion exchange chromatography 
(18, 19), and recovery of radioactivity in individual sugars was deter- 
mined as described under “Materials and Methods.” 
GLUCOSE CONCENTRATION (mM) 
FIG. 7. Rate of glucosylation of rat albumin as a function of glucose concentration. Hat albumin, 7 mg/ml of phosphate-buffered 
saline, was incubated with indicated concentrations of glucose made to a final specific activity of 4 x 10’ cpm/l.rmol. A, acid-precipitable 
radioactivity in aliquots removed at indicated times was determined as described under “Materials and Methods.” B, initial reaction rates 
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FIG. 8. Rate of glucosylation of rat albumin as a function of albumin concentration. Rat albumin at indicated concentrations was 
incubated in phosphate-buffered saline containing 5 mM glucose (4 x 10” cpm/pmol). A, acid-precipitable radioactivity in aliquots removed at 
indicated times was determined as described under “Materials and Methods.” B, initial reaction rates shown in A are plotted as a function of 
albumin concentration. 
r 
12 3 4 5 6 7 6 
TIMEtDAYS) 
FIG. 9. Rate of glucosylation of rat albumin as a function of 
temperature. Rat albumin, 25 mg/ml, was incubated in phosphate- 
buffered saline containing 5.0 mM glucose (4 X 10” cpm/pmol) and 
acid-precipitable radioactivity in aliquots removed at indicated times 
was determined as described under “Materials and Methods.” 
temperature-dependent, but an Arrhenius plot of the data has 
a convex curvature, prohibiting a straightforward determina- 
tion of the activation energy of the glucosylation reaction. 
The extent of reaction was negligible during 120 days storage 
in the freezer at -20°C. 
In Vivo Studies-In order to estimate the rate of formation 
of glucosylated albumin in uiuo, and to evaluate its in vivo 
stability, animals were injected with either unglucosylated or 
glucosylated ““I-albumin. Carboxymethylcellulose chroma- 
tography of the albumin reisolated at various times postinjec- 
tion was used to monitor any shifts of lz51 radioactivity from 
one form of the albumin to the other. At 1 and 3 days 
postinjection of ‘“51-unglucosylated albumin, 3.0 and 7.9%, 
respectively, of the recovered ““I-albumin was found in the 
glucosylated fraction. These results document that glucosyl- 
ation is a post-translational modification occurring in the 
circulation. Glucosylation is apparently an irreversible process 
in vivo since no lz51 radioactivity was recovered from the 
unglucosylated region of the carboxymethylcellulose column 







FIG. 10. Kinetics of clearance of glucosylated and ungluco- 
sylated ‘251-albumins from the rat circulation. Albumin was 
iodinated, glucosylated, and separated into glucosylated and unglu- 
cosylated components by carboxymethylcellulose chromatography, 
all as described under “Materials and Methods.” Animals (two/ex- 
periment) were injected with one or the other form of the albumin, 
and the disappearance of la5 I radioactivity from the circulation mon- 
itored in blood samples taken at indicated times. Time of equilibration 
of albumin into extravascular space indicated by - - -. 
The structure of carbohydrate side chains are known to 
influence profoundly the metabolism of plasma proteins. 
Therefore, we investigated the possible role of glucosylation 
in regulating albumin clearance from the circulation, by study- 
ing the half-lives of glucosylated and unglucosylated 12”1-al- 
bumin. Iodination was carried out prior to glucosylation to 
avoid the possibility that the conditions of iodination might 
modify the nature of the glucosyl adduct. The circulating half- 
life of both iodinated forms of albumin (Fig. 10) was found to 
be 48 h, indicating that glucosylation does not affect the 
fractional catabolic rate for albumin in the circulation. 
Since the rate of glucosylation in vitro is first order with 

























Nonenzymatic Ghcosylation of Serum Proteins 9399 
TABLE III 
Relationship between blood glucose and levels of glucosylated 
urotein in control and diabetic rats 
Normal Diz&&km- Diabetic + insulin 
Blood glucose mg/lOO mlh 70, 73.5 434,444 go,92 
% Glucosvlated albumin’ 7.2. 8.1 31.0, 33.8 18.8, 18.0 
” Data are for two rats maintained under each set of conditions 
described under “Materials and Methods.” 
* Measured by glucose-oxidase peroxidase procedure. 
‘Determined by CM-cellulose chromatography as described for 
Fig. 5. 
cosylation of albumin might be expected to occur during 
diabetic hyperglycemia in uiuo. In addition, because glucosyl- 
ation does not affect the half-life of albumin in the circulation 
(Fig. lo), higher steady state levels of glucosylated albumin 
should be observed in diabetic animals. This prediction was 
confirmed by measurements of per cent glucosylated albumin 
in normal and diabetic rata (Table III). Highest levels of 
glucosylated albumin are observed in untreated, diabetic ani- 
mals, and the 4-fold elevation of glucosylated albumin is 
comparable to the 6-fold increase in blood sugar. A significant, 
2.5-fold, elevation in glucosylated albumin is also observed in 
insulin-treated diabetic animals, suggesting that overall con- 
trol of hyperglycemia is suboptimal although fasting blood 
glucose is near normal. 
DISCUSSION 
The studies presented here, along with our previous report 
(12), indicate that nonenzymatic glucosylation is a common 
post-translational modification of serum proteins. The obser- 
vation that albumin is particularly reactive to nonenzymatic 
glucosylation, its ease of purification, and the fact that albu- 
min is a well characterized plasma protein led us to investigate 
nonenzymatic glucosylation of this protein as a model for 
other plasma proteins. 
The rate of glucosylation of rat albumin in vitro appears to 
be fiit order with respect to glucose concentration, but slows 
down abruptly after transfer of approximately 1 mol of glu- 
cose/mol of protein (Fig. 7A), suggesting the presence of a 
single, rapidly modified amino acid residue, and other less 
reactive secondary sites. From studies of glucosylated albumin 
prepared in vitro, we have identified a lysine residue(s) as the 
major site(s) of glucosylation of albumin (Fig. 6). The inhibi- 
tion of glucosylation by aspirin (acetylsalicylic acid) suggests 
that this is the same low pK lysine residue which is acetylated 
by aspirin (25). Studies are in progress to verify this assign- 
ment. 
Variations in oxygen binding equilibria for several HbAi 
subfractions have been documented (4, 5) suggesting long 
range conformational alterations in hemoglobin’s tertiary or 
quaternary structure upon glucosylation. Similarly, glucosyl- 
ation of albumin might also affect its affinity for a variety of 
ligands, including fatty acids, bilirubin, clinical dyes, and 
pharmacological agents. As a minimum, glucosylation un- 
doubtedly contributes to the well known structural micro- 
heterogeneity of albumin (26), and may be responsible for 
some of the multiple electrophoretic forms observed for this 
and other proteins by high resolution techniques. 
While the actual mechanisms regulating plasma protein 
catabolism are poorly understood, there is good evidence that 
albumin is catabolized, at least in part, directly from the 
vascular compartment (27). Foster has suggested that albu- 
min’s catabolism may be the end result of a series of chemical 
or enzymatic insults to the protein, which take place in the 
circulation, and contribute to its gradual denaturation (26). 
Since variations in the structure of carbohydrate side chains 
are known to have a critical role in regulating the uptake and 
catabolism of circulating glycoproteins (28, 29), we hypothe- 
sized that glucosylation might be a chemical insult initiating 
albumin’s catabolism. Our data, however, do not support this 
hypothesis (Fig. lo), but suggest that glucose attached non- 
enzymatically to albumin does not serve as a recognition 
marker triggering specific removal of the glycoprotein from 
the circulation in normal rata. 
Since glucosylation does not affect albumin’s circulating 
half-life, it is possible, by a relatively straightforward kinetic 
analysis, to predict the steady state level of glucosylated 
albumin in uiuo from knowledge of the kinetics of glucosyla- 
tion and catabolism of albumin in uiuo. The relationship may 
be written: 
d[GAl - = k’,[A] - kz[GA] dt 
where GA = glucosylated albumin, A = unglucosylated albu- 
min, and k’, and k:! are rate constants for glucosylation and 
catabolism of albumin. (For convenience k’l is treated here as 
a pseudo-fist order rate constant, although the synthetic 
reaction is second order overall, i.e. k’, = kl [glucose].) Then, 







The in uiuo rate constant, k’,, can be estimated from the 
observation that about 7.9% of injected, unglucosylated 1251- 
albumin isolated at 3 days postinjection was recovered as the 
glucosylated form. Thus, k’, = 0.026 day-’ = 0.0011 h-‘. 
Similarly, from the half-life of glucosylated albumin shown in 
Fig. 10, 
k = 06g3 - 06g3 - 0.014 h-1, 2- 
h/2 48 h 
These estimates of rate constants are, within experimental 
error, consistent with the observed steady state level of glu- 
cosylated albumin in rat serum, as predicted in Equation I, 
i.e. 
k’, 0.0011 h-’ -= 
kz o.014 h-, = 0.078 
and, since approximately 6.7% of albumin exists normally in 
the glucosylated form, 
[GA] = 0.067 = 0,072, 
[Al 0.93 
The agreement between these two ratios indicates that the 
rate of nonenzymatic glucosylation in the extracellular com- 
partment in uiuo is adequate to explain the steady state level 
of glucosylated albumin in the circulation, and argues that 
glucosylation occurs as a postsecretory, rather than an intra- 
cellular, event. The rate of glucosylation of albumin observed 
in serum at 37°C in vitro, 37% in 200 h, k’, = 0.0018 h-’ (data 
not shown) is reasonably close to the value observed in uiuo. 
However, the rate observed with purified albumin at 37°C in 
vitro was faster, 61% in 200 h, k’l = 0.0031 h-l; thus, the 
glucosylation reaction proceeds more rapidly with the pure 
protein in vitro, suggesting that other ligands bound to albu- 
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In the past, the detection of low levels of glucose in non- 
collagen glycoproteins has often been attributed to trace con- 
tamination by cellulosic materials. Within the last few years, 
however, glucose has been identified as a component of the 
oligosaccharide of both lysosomal enzymes (30) and intracel- 
lular intermediates in the processing of secreted and mem- 
brane glycoproteins (31). It was important, therefore, to de- 
termine the extent to which nonenzymatically bound glucose 
could interfere with analyses for glucose in glycosidic linkage 
to protein. From the data in Table II, however, it is clear that 
nonenzymatically bound glucose is not likely to affect carbo- 
hydrate analyses on glycoproteins. Only trace amounts (~5%) 
of free glucose or mannose were released under standard 
conditions for hydrolysis of neutral sugars. Since more than 
75% of the radioactivity in the hydrolysates was partially or 
completely excluded from Bio-Gel P-2, and adsorbed to mixed 
bed resins, it is likely that the glucose residue is released from 
the protein in a peptide-bound form. Based on the model 
studies of Heyns et al. (2,32), the glucose may be found in the 
peptide as an e-N-(2furoyhnethyl)- derivative of lysine. 
In the preliminary experiments reported here, we observed 
that untreated diabetic hyperglycemia in the rat results in 
about a 4-fold increase in per cent glucosylated albumin, while 
insulin-treated diabetic rats have about a 2-fold elevation. It 
should be emphasized that the insulin regimen used in these 
experiments is designed both to provide for the convenient, 
daily administration of a long acting insulin, and to be ade- 
quate to prevent glucosuria and ketoacidosis. However, the 
regimen is not optimized for the individual animals, and 
variations in blood glucose do occur during the daily cycle. In 
fact, the elevated level of glucosylated albumin in the insulin- 
treated animals may be a better indicator of a mild hypergly- 
cemic state than the single fasting blood glucose measure- 
ments. Further studies in rata which monitor changes in per 
cent glucosylated albumin during both uncontrolled hypergly- 
cemia and therapeutic management with insulin should per- 
mit an evaluation of the sensitivity of glucosylated albumin to 
average blood glucose levels. The enhanced levels of glucosyl- 
ated albumin detected in diabetic rata suggest that measure- 
ments of albumin glucosylation in man may also be useful in 
the detection and management of diabetes, 
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